Exploring biomarkers for prognosis and neoadjuvant chemosensitivity in rectal cancer: Multi-omics and ctDNA sequencing collaboration
IntroductionThis study aimed to identified the key genes and sequencing metrics for predicting prognosis and efficacy of neoadjuvant chemotherapy (nCT) in rectal cancer (RC) based on genomic DNA sequencing in samples with different origin and multi-omics association database.MethodsWe collected 16 R...
Main Authors: | Xiu-Feng Jiang, Bo-Miao Zhang, Fen-Qi Du, Jun-Nan Guo, Dan Wang, Yi-En Li, Shen-Hui Deng, Bin-Bin Cui, Yan-Long Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1013828/full |
Similar Items
-
Neoadjuvant chemotherapy in the treatment of rectal cancer without mesorectal fascia involvement but with negative prognostic factors
by: S. O. Kochkina, et al.
Published: (2020-08-01) -
Adoption of Total Neoadjuvant Therapy in the Treatment of Locally Advanced Rectal Cancer
by: Madison L. Conces, et al.
Published: (2024-01-01) -
Recent advance in neoadjuvant chemotherapy for rectal cancer
by: GUO Yang, GUO Tian′an, XU Ye
Published: (2022-07-01) -
Neoadjuvant therapy for locally advanced rectal cancer
by: M. Yu. Fedyanin, et al.
Published: (2022-06-01) -
Total neoadjuvant therapy for rectal cancer: evidence and challenge
by: Suk-Hwan Lee
Published: (2023-08-01)